The Food and Drug Administration is warning consumers to steer clear of Optimized Plant Mediated Solutions (OPMS) Black Liquid Kratom after officials allege the product can be linked to health conditions and death.
The FDA’s announcement comes after an investigation into the product following a slew of reports detailing users’ adverse health events and the death of a 23-year-old Georgia man who died in December 2021. Mitragyna speciosa, or kratom, is a plant that derives from Southeast Asia. Though the product is marketed as “all-natural” and is a plant supplement, it has yet to be approved by the FDA.
Some of the reported health concerns linked to the use of kratom include withdrawals, addiction, increased anxiety, digestive issues and restless leg syndrome. This condition causes patients to feel discomfort in their legs and have a compulsion to frequently move or shift them, especially at night or when resting.